novel
coronaviru
identifi
caus
agent
massiv
outbreak
atyp
pneumonia
origin
wuhan
hubei
provinc
china
involv
format
coronaviru
replic
complex
viral
main
proteas
pro
also
call
pro
repres
attract
target
therapi
determin
crystal
structur
unligand
pro
resolut
use
structur
guid
optim
seri
alphaketoamid
inhibitor
main
goal
optim
effort
improv
pharmacokinet
properti
compound
describ
crystal
structur
complex
enzym
potent
alphaketoamid
optim
way
structur
form
basi
develop
compound
antivir
drug
authorfund
right
reserv
reus
allow
without
permiss
sinc
decemb
new
coronaviru
emerg
citi
wuhan
capit
hubei
provinc
china
wherea
begin
outbreak
case
connect
huanan
seafood
anim
market
wuhan
effici
humantohuman
transmiss
led
exponenti
growth
number
case
count
stand
today
casefat
rate
rna
genom
featur
ident
sar
coronaviru
sarscov
virus
belong
clade
b
genu
betacoronaviru
henc
propos
renam
new
viru
gorbalenya
et
al
one
best
character
drug
target
among
coronavirus
main
proteas
pro
also
call
pro
along
papainlik
proteas
enzym
essenti
process
polyprotein
translat
viral
rna
hilgenfeld
pro
oper
less
cleavag
site
larg
polyprotein
replicas
kda
recognit
sequenc
site
leu
ser
ala
gli
mark
cleavag
site
inhibit
activ
enzym
block
viral
replic
sinc
human
proteas
similar
cleavag
specif
known
chanc
inhibitor
exhibit
low
toxic
report
crystal
structur
pro
unligand
form
usag
structur
design
new
aketoamid
inhibitor
compound
compound
develop
basi
firstgener
peptidomimet
aketoamid
design
broadspectrum
antivir
target
pro
betacov
alphacov
well
proteas
enterovirus
compar
inhibitor
cystein
proteas
aketoamid
advantag
bear
rel
mild
electrophil
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
warhead
interact
catalyt
center
target
enzym
two
hydrogen
bond
rather
one
addit
coval
bond
form
nucleophil
attack
catalyt
cystein
onto
aketo
moieti
crystal
structur
unligand
pro
fig
reveal
high
similar
sarscov
pro
expect
sequenc
comparison
zhou
et
al
wu
et
al
rm
deviat
two
freeenzym
structur
ca
posit
molecul
isol
domain
exhibit
rm
deviat
domain
ii
domain
iii
comparison
novel
coronaviru
pro
structur
sarscov
pro
pdb
entri
tan
et
al
chymotrypsinand
picornaviru
proteaselik
domain
ii
residu
respect
sixstrand
antiparallel
bbarrel
harbor
substratebind
site
domain
iii
residu
globular
cluster
five
helic
involv
regul
dimer
format
pro
shi
song
pro
form
tight
dimer
contact
interfac
predominantli
domain
ii
molecul
residu
molecul
b
nfinger
two
molecul
orient
perpendicular
one
anoth
fig
dimer
enzym
necessari
catalyt
activ
nfinger
two
protom
interact
glu
protom
therebi
help
shape
pocket
substratebind
site
anand
et
al
reach
interact
site
nfinger
squeez
domain
ii
iii
parent
monom
domain
ii
monom
interestingli
sarscov
pro
dimer
polar
interact
two
domain
iii
involv
hydrogen
bond
sidechain
hydroxyl
group
residu
thr
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
protom
support
hydrophob
contact
sidechain
ile
thr
threonin
replac
alanin
indic
black
sphere
fig
isoleucin
leucin
previous
shown
replac
ser
thr
ile
alanin
residu
sarscov
pro
lead
enhanc
catalyt
activ
proteas
concomit
slightli
closer
pack
two
domain
iii
dimer
one
anoth
lim
et
al
accord
studi
accompani
chang
structur
dynam
enzym
transmit
effect
mutat
catalyt
center
inde
thr
ala
replac
observ
pro
also
allow
two
domain
iii
approach
littl
closer
distanc
ca
atom
residu
molecul
b
sarscov
pro
pro
distanc
center
mass
two
domain
iii
shrink
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
posit
ala
two
domain
iii
see
text
chain
termini
label
n
c
molecul
light
blue
n
c
molecul
b
orang
activ
site
pro
cy
form
catalyt
dyad
like
sarscov
pro
coronaviru
homologu
buri
water
molecul
found
hydrogenbond
could
consid
third
compon
catalyt
triad
scheme
chemic
structur
aketoamid
inhibitor
previous
design
synthes
peptidomimet
aketoamid
broadspectrum
inhibitor
main
proteas
betacoronavirus
alphacoronavirus
well
proteas
enterovirus
best
compound
see
scheme
show
picomolar
merscov
cell
well
low
micromolar
valu
sarscov
whole
rang
enterovirus
variou
cell
line
order
improv
halflif
solubl
compound
human
plasma
reduc
bind
plasma
protein
modifi
compound
hide
amid
bond
within
pyridon
ring
replac
cinnamoyl
group
compound
relat
modifi
way
compound
halflif
human
plasma
increas
solubl
improv
plasma
protein
bind
reduc
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
sign
toxic
mice
addit
show
good
metabol
stabil
use
mous
human
microsom
intrins
clearanc
rate
cl
intmous
protein
cl
inthuman
protein
mean
min
around
mous
human
respect
residu
compound
remain
metabol
stabl
pharmacokinet
studi
mice
use
subcutan
rout
mgkg
show
stay
plasma
hr
excret
via
urin
hr
cmax
determin
ngml
mean
resid
time
hr
although
seem
clear
rapidli
plasma
found
hr
ngg
tissu
lung
ngml
broncheoalveolar
lavag
fluid
balf
suggest
mainli
distribut
tissu
light
current
cov
outbreak
advis
develop
compound
lung
tropism
howev
compar
structur
modif
led
loss
inhibitori
activ
main
proteas
um
well
proteas
enterovirus
enhanc
antivir
activ
betacoronavirus
clade
b
sarscov
sacrif
goal
broadspectrum
activ
includ
enterovirus
time
replac
cyclohexyl
moieti
cyclopropyl
pocket
betacoronaviru
main
proteas
show
pronounc
plastic
enabl
adapt
shape
smaller
inhibitor
moieti
enter
site
present
xray
crystal
structur
two
differ
crystal
form
resolut
complex
aketoamid
optim
way
pro
fig
one
structur
space
group
protom
pro
dimer
bound
crystal
symmetri
ident
conform
space
group
two
protom
independ
free
adopt
differ
conform
inde
find
latter
crystal
structur
key
residu
glu
adopt
inact
conform
evidenc
prolong
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
distanc
lack
hbond
interact
glu
moieti
inhibitor
see
even
though
compound
bound
mode
molecul
phenomenon
also
observ
pronounc
form
sarscov
pro
yang
et
al
consist
halfsit
activ
describ
enzym
chen
et
al
copi
inhibit
pro
inhibitor
bind
shallow
substratebind
site
surfac
protom
domain
ii
fig
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
nucleophil
attack
catalyt
cy
onto
aketo
group
inhibitor
thiohemiket
form
revers
reaction
clearli
reflect
electron
densiti
fig
stereochemistri
chiral
moieti
three
copi
compound
structur
oxyanion
hydroxyl
group
thiohemiket
stabil
hydrogen
bond
wherea
amid
oxygen
accept
hydrogen
bond
mainchain
amid
gli
cy
partli
ser
form
canon
oxyanion
hole
cystein
proteas
glactam
moieti
design
glutamin
surrog
dragovich
et
al
tan
et
al
deepli
embed
pocket
proteas
lactam
amid
nitrogen
donat
threecent
bifurc
hydrogen
bond
mainchain
oxygen
phe
valu
structur
space
group
group
molecul
aspac
group
molecul
b
glu
carboxyl
carbonyl
oxygen
accept
hbond
imidazol
cyclopropyl
methyl
moieti
embrac
subsit
shrunk
compar
complex
compound
cyclohexyl
methyl
sarscov
pro
llz
et
al
unpublish
pyridon
posit
inhibitor
occupi
space
normal
fill
substrat
main
chain
carbonyl
oxygen
accept
hydrogen
bond
mainchain
amid
residu
amid
donat
hbond
mainchain
oxygen
glu
embed
within
pyridon
nitrogen
longer
donat
hydrogen
bond
protein
howev
previou
crystal
structur
show
mainchain
amid
linear
aketoamid
make
hydrogen
bond
protein
case
interact
seem
essenti
boc
group
occupi
canon
site
proteas
locat
near
pro
distanc
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
due
interact
latter
residu
push
compar
structur
free
enzym
contact
explain
remov
boc
group
weaken
inhibitori
potenc
compound
factor
interestingli
space
pyridon
ring
main
chain
residu
thr
sidechain
gln
fill
dmso
molecul
crystal
structur
water
molecul
structur
suggest
moieti
bulki
pyridon
may
accept
next
step
develop
compound
toward
potenti
drug
target
coronavirus
undertak
test
virusinfect
cell
cultur
smallanim
model
becom
avail
meanwhil
crystal
structur
may
use
other
virtual
screen
denovo
design
inhibitor
anand
k
palm
g
j
mester
j
r
siddel
g
ziebuhr
j
hilgenfeld
r
structur
coronaviru
main
proteinas
reveal
combin
chymotrypsin
fold
extra
alphahel
domain
embo
j
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
